Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP ‐1 Receptor Agonists
Annals of Clinical and Translational Neurology · 2026-11 · 13 (11) · 2289-2302
DOI: 10.1002/acn3.70406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 17.04.2026. Verfasst von Faisal A Al-Harbi und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Qassim University, Buraydah, Saudi Arabia. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Optic Neuropathy, Ischemic, Pseudotumor Cerebri, Optic Atrophy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged. Hence, this study was designed to examine the relationship between GLP‐1 RA use and optic outcomes in IIH patients.
Methods
This study used the TriNetX Global Collaborative Network to perform a retrospective propensity score‐matched cohort study. It involved GLP‐1 RA exposure status to classify adult patients with IIH. Further, it applied propensity score matching (PSM) on demographics, comorbidities, and medications. In this study, the primary outcome was incident NAION; the secondary outcome was optic atrophy. Cox proportional hazards regression, time‐stratified analyses, and multiple testing corrections were performed.
Results
From 144,678 IIH patients, 15,567 matched pairs were analyzed. GLP‐1 RA use demonstrated significantly decreased NAION risk (hazard ratio [HR] 0.47, 95% confidence interval [CI] 0.24–0.93, p = 0.027) and optic atrophy risk (HR 0.78, 95% CI 0.64–0.94, p = 0.009). Time‐stratified analyses have demonstrated protective associations across all evaluated time windows. The optic atrophy finding remained significant after Bonferroni correction, while NAION remained significant after false discovery rate correction. Subgroup analysis revealed stronger protective associations in non‐diabetic patients (risk ratio 0.53, 95% CI 0.41–0.68) compared to diabetic patients (risk ratio 0.76, 95% CI 0.58–0.99).
Conclusions
GLP‐1 RA utilization among IIH patients was associated with a reduced risk of NAION and optic atrophy. These findings align with the proposed pathway linking GLP‐1 RA‐induced weight reduction to lower intracranial pressure and papilledema reduction in IIH patients; residual confounding cannot be ruled out, and prospective studies are needed to confirm these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Qassim University, Buraydah, Saudi Arabia.
- College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
- College of Medicine, Al-Rayan Colleges, Al-Madinah, Saudi Arabia.
- Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
- Qassim Health Cluster, Qassim, Saudi Arabia.
- College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
ORCID-Profile: Faisal A Al-Harbi, Mohanad A Alkuwaiti, Ahmed Y Azzam
Zitieren
APA
Al-Harbi, F. A., Alkuwaiti, M. A., Alaql, Y. B., Alsaif, A. K., Alessa, A. A., Alharbi, M. A., Alfalah, M., Alnaaim, S. A., AlHaddad, S. M., & Azzam, A. Y. (2026). Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP ‐1 Receptor Agonists. Annals of Clinical and Translational Neurology, 13(11), 2289-2302. https://doi.org/10.1002/acn3.70406
Vancouver
Al-Harbi FA, Alkuwaiti MA, Alaql YB, Alsaif AK, Alessa AA, Alharbi MA, et al. Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP ‐1 Receptor Agonists. Annals of Clinical and Translational Neurology. 2026;13(11):2289-2302. doi:10.1002/acn3.70406
BibTeX
@article{AlHarbi2026,
author = {Al-Harbi, Faisal A and Alkuwaiti, Mohanad A and Alaql, Yazeed B and Alsaif, Ahmed K and Alessa, Ahmed A and Alharbi, Meshari Ayed and Alfalah, Mohammed and Alnaaim, Saud A and AlHaddad, Sajjad M and Azzam, Ahmed Y},
title = {Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP ‐1 Receptor Agonists},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
volume = {13},
number = {11},
pages = {2289--2302},
doi = {10.1002/acn3.70406}
}
EUVIMED